Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 25;14:952038. doi: 10.3389/fnagi.2022.952038

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Li, Han, Luo, Huang, Huang, Li, Huang, Chen and Wu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Average serum MMP-9 and BDNF levels of AIS patients with or without thrombolysis at Day 1, Day 2, and Day 5 time points. (A) Bar graph shows quantitative analysis for serum MMP-9 of patients with non-thrombolysis between good prognosis group (n = 15) and poor prognosis group (n = 8). (B) Bar graph shows quantitative analysis for serum BDNF of patients with non-thrombolysis between good prognosis group (n = 9) and poor prognosis group (n = 10). (C) Bar graph shows quantitative analysis for serum MMP-9 of patients with thrombolysis between good prognosis group (n = 15) and poor prognosis group (n = 8). (D) Bar graph shows quantitative analysis for serum BDNF of patients with thrombolysis between good prognosis group (n = 9) and poor prognosis group (n = 10). Data represent as mean ± SD, *P < 0.05, ^**P < 0.01 vs. Day 1 time points, ^ΔP < 0.05, ^ΔΔP < 0.01 vs. group with good prognosis.